METAVIA INC. Other Non-Current Assets
METAVIA INC. (MTVA) had Other Non-Current Assets of $21.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $21.00K.
- 2026-03-31: Other Assets, Noncurrent $21.00K.
- 2025-12-31: Other Assets, Noncurrent $21.00K.
- 2025-09-30: Other Assets, Noncurrent $21.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $21.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $21.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $21.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $21.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $21.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $21.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $21.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $21.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $21.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $21.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $21.00K 10-Q · filed 2023-11-13 |
| 2021-06-30 | $134.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $143.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $155.00K 10-Q · filed 2021-08-16 |
| 2020-09-30 | $33.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $32.00K 10-Q · filed 2020-08-11 |
| 2019-12-31 | $34.00K 10-Q · filed 2020-11-13 |
| 2017-09-30 | $8.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $30.00K 10-Q · filed 2017-08-14 |
| 2016-12-31 | $8.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |